Literature DB >> 3675451

Maternal narcotic addiction: pregnancy outcome in patients managed by a specialized drug-dependency antenatal clinic.

D A Ellwood1, P Sutherland, C Kent, M O'Connor.   

Abstract

A retrospective analysis has been made of the outcome of pregnancy in 174 women abusing narcotics, managed by a specialist team from a drug-dependency antenatal clinic. These women were cared for through 182 pregnancies of greater than 20 weeks' gestation, resulting in 183 live and 5 stillbirths. The majority of patients were enrolled in a methadone programme and stabilized on the drug before the third trimester. The group was characterized by a high prevalence of previous obstetric and medical problems. The most common antenatal complications were preterm labour (24%) and anaemia (12%). Preterm delivery and small-for-gestational-age each occurred in a quarter of pregnancies. The mean birth-weight for the group was 2,746 g +/- 721 g; mean +/- S.D. Eight perinatal deaths occurred (5 stillbirths, 3 neonatal deaths), giving a perinatal mortality rate of 43/1,000. The data on narcotic abusers have been compared with similar data obtained from randomly selected public antenatal clinic patients who delivered during the same period.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3675451     DOI: 10.1111/j.1479-828x.1987.tb00952.x

Source DB:  PubMed          Journal:  Aust N Z J Obstet Gynaecol        ISSN: 0004-8666            Impact factor:   2.100


  9 in total

Review 1.  Effects of in utero exposure to street drugs.

Authors: 
Journal:  Am J Public Health       Date:  1993-12       Impact factor: 9.308

2.  Comprehensive treatment program for pregnant substance users in a family medicine clinic.

Authors:  Alice Ordean; Meldon Kahan
Journal:  Can Fam Physician       Date:  2011-11       Impact factor: 3.275

3.  Changes to methadone clearance during pregnancy.

Authors:  Kim Wolff; Annabel Boys; Amin Rostami-Hodjegan; Alastair Hay; Duncan Raistrick
Journal:  Eur J Clin Pharmacol       Date:  2005-10-29       Impact factor: 2.953

Review 4.  Maternal Use of Opioids During Pregnancy and Congenital Malformations: A Systematic Review.

Authors:  Jennifer N Lind; Julia D Interrante; Elizabeth C Ailes; Suzanne M Gilboa; Sara Khan; Meghan T Frey; April L Dawson; Margaret A Honein; Nicole F Dowling; Hilda Razzaghi; Andreea A Creanga; Cheryl S Broussard
Journal:  Pediatrics       Date:  2017-06       Impact factor: 7.124

5.  Comparison of characteristics of opioid-using pregnant women in rural and urban settings.

Authors:  Sarah H Heil; Stacey C Sigmon; Hendree E Jones; Michael Wagner
Journal:  Am J Drug Alcohol Abuse       Date:  2008       Impact factor: 3.829

6.  Cognitive and Motor Outcomes of Children With Prenatal Opioid Exposure: A Systematic Review and Meta-analysis.

Authors:  Su Lynn Yeoh; John Eastwood; Ian M Wright; Rachael Morton; Edward Melhuish; Meredith Ward; Ju Lee Oei
Journal:  JAMA Netw Open       Date:  2019-07-03

7.  Opioid exposure during pregnancy and the risk of congenital malformation: a meta-analysis of cohort studies.

Authors:  Xinrui Wang; Yushu Wang; Borui Tang; Xin Feng
Journal:  BMC Pregnancy Childbirth       Date:  2022-05-11       Impact factor: 3.105

8.  Maternal and neonatal effects of substance abuse during pregnancy: our ten-year experience.

Authors:  Mirjana Vucinovic; Damir Roje; Zoran Vucinovic; Vesna Capkun; Marija Bucat; Ivo Banovic
Journal:  Yonsei Med J       Date:  2008-10-31       Impact factor: 2.759

9.  The effects of maternally administered methadone, buprenorphine and naltrexone on offspring: review of human and animal data.

Authors:  W O Farid; S A Dunlop; R J Tait; G K Hulse
Journal:  Curr Neuropharmacol       Date:  2008-06       Impact factor: 7.363

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.